Introduction
It is about eight years since prophylactic anti-D gammaglobulin became generally available to prevent immunisation of rhesus-negative women. Since babies still die from the disease we decided to look at the circumstances in which those women who had dead babies in 1977 had become immunised. We have suggested' that inaccuracies in death certification and in classifying causes of death might lead to wrong conclusions in epidemiological research. The present survey provides a useful series in which to look at this problem.
Methods
In response to our request for information on all deaths from rhesus (and other) haemolytic disease of the newborn (HDN) in England and Wales during 1977 copies of the death certificates of 54 liveborn babies and of 101 stillbirths were provided by the Office of Population Censuses and Surveys (OPCS). The usual coding on the certificate was 774 and 775 with their subunits (see key), these rubrics relating to cases where HDN was given as the primary ("underlying") cause of death. ' Part I of a death certificate deals with the causes leading directly to death, where section (a) the direct cause is due to (b) the intervening antecedent cause, which is due to (c) the underlying antecedent cause. The general rule is that the certified cause of death is the entry on the lowest line used in part I. Part II of the death certificate deals with other conditions contributing to the death but not related to the disease causing it.
As well as recording certified causes of death the OPCS undertakes an additional procedure-multiple coding. To use all the medical information on death certificates, experiments during the last 10 years have been carried out in coding all causes mentioned. Since 1974 a 250o sample of death certificates has been so analysed. Whenever HDN occurs as an "antecedent" or "subsidiary" cause on a certificate it is coded 774 or 775, and these additional cases are stored in the Table III shows how the mothers of the liveborn and stillborn infants had become immunised and whether anti-D had been given. advised for all women known to be Rh-negative who had abortions before the 21st week of pregnancy, and after 20 weeks the standard dose of 100 itg was advised.) l;
Many of our cases, particularly the stillbirths, fell into the category (1) where the mother had been immunised before anti-D was available. This is not surprising, bearing in mind the dates when prophylaxis was introduced, since rhesus disease usually occurs in multiparas, the second affected baby tends to be more severely affected than the first, and we studied only deaths. About two of the infants of untreated mothers will have rhesus HDN, and, with a mortality of about 1500O there will be 0-3 deaths in the offspring of the untreated mothers. On the other hand, we know from the MRC trials8 that, in the offspring of the 80% treated, the incidence of rhesus HDN will amount to only about 1-5">, and deaths to 0.1 to 0-15. Therefore 65% to 750(, of deaths from rhesus HDN will be among infants born to the 20',, of women who have not been treated.
It is interesting to compare our results with those from an area where virtually the whole population is known to be protected. In Connecticut (population 3-5 million) almost all women have their confinement in hospital, and over 990,) of those eligible for anti-D prophylaxis receive it. In 1977 there were three deaths there from rhesus HDN9: in two immunisation occurred before anti-D was available and in one (a stillbirth) during the pregnancy in which the fetus died. Since the birth rate in Connecticut is about the same as in Britain and the population about 1/16th of that in England and Wales we should have had only about 50 deaths, all in categories 1-3 (assuming roughly the same management of pregnancy) if we had had full coverage by anti-D.
Discussion
The first practical question is how to improve the coverage by anti-D. Among all the other necessary activities associated with a birth a relatively new and very simple procedure can easily be forgotten, but if, as in some hospitals, it was the responsibility of one particular person-for example, a midwife or one of the pathology laboratory staff-this should help.
Until the loopholes in the postnatal anti-D programme have been closed it is unjustifiable to start an antenatal anti-D programme, which is much more complicated. Anti-D production would have to be increased by a factor of 4-4, putting more donors to inconvenience and possible future risks, to say nothing of added expense. When the postnatal programme has been fully implemented there would then be a strong case for combining postnatal with antenatal anti-D.
The second problem is how to improve the accuracy of death certification and coding, so that epidemiological studies become more reliable. Walker and Mollison,"0 when investigating the circumstances of every death certified as due to HDN (particularly in relation to exchange transfusion), found that 97 of their 409 traced cases (ascertained through death certificates) were not due to HDN, the main error concerning kernicterus of prematurity and (as in our series) non-haemolytic hydrops. But Knox,'" for example, took no account of the type of error we have described when he was forecasting trends in HDN. The fact that there is a "levelling out" of the curve showing a fall in the incidence of death from rhesus HDN might have been caused by the group of cases incorrectly certified because these will form an irreducible residuum. The paper by Tovey et all2 is not subject to the same criticism because it deals with immunisation rates.
Compared with many other procedures that junior staff have to learn, the accurate filling in of a death certificate and the appreciation of its importance are simple. All that doctors need is some basic information (with examples), and they should know that the coders are only rarely permitted to override the sequence written by a doctor. It would also help if those responsible for the International Classification of Diseases could give more specific instructions about conditions such as hydrops for which there are many causes. The 9th revision of the International Classification of Diseases,"3 which came into effect on 1 January 1979, gave an opportunity for this, and there are now more details about the classification of hydrops. Nevertheless, in the 8th edition2 category 778-9 was reserved for "Hydrops of newborn, not due to haemolytic disease."
We have already pointed out that errors in death certification are found in many conditions,' but we have been taken to task on several grounds: we exaggerated the discrepancies; death certificates are not intended for research purposes; mistakes cancel each other out; and what we wrote has been stated more clearly by others.'4" We accept some of these criticisms but by studying a special problem in detail, as we have done here, we think that many of them have been answered.
We have also refuted the idea that doctors are not willing to discuss problem cases.. Before we began our study Sir John Dewhurst, then president of the Royal College of Obstetricians and Gynaecologists, kindly put a notice in the Newsletter of the Royal College of Obstetricians and Gynaecologists, asking obstetricians to give us their co-operation, and this undoubtedly contributed to the 10000 ascertainment-all 54 of the liveborn infants and all of the 101 stillbirths. The obstetricians sent us not only the notes of their cases but often their detailed views on the cause of death, which were most helpful, particularly in deciding that death was not due to haemolytic disease. 
ONE HUNDRED YEARS AGO
The following are the conclusions at which Dr Martin has arrived in his recent thesis for the doctor's degree, regarding disorders of the eyes produced by tobacco. 1. It is easy to distinguish between amblyopia caused by alcoholic poisoning and by abuse of nicotine, as in both cases the affection presents characteristic symptoms. 2. The most important of these symptoms is the condition of the pupil, which is dilated in alcoholic amblyopia and contracted in the other case. In the first case, the affection progresses irregularly and with occasional changes for the better, which are followed by relapses; while, in the second case, its progress is slow but uninterrupted. In the one, both eyes are always affected to the same extent; in the other, they are not both affected, or at least not simultaneously. The patients do not see as well at night as durinig the daytime, and do not suffer from hallucinations, illusions of sight, or diplopia. In alcoholic amblyopia, on the contrary, the patients cannot bear a strong light, see better during the night, and complaiin of hallucinations, polyopia, and diplopia. 
